Neuro Biotech Alto Adds $128M in IPO Cash for Biomarker-Based Psych Drugs

Retrieved on: 2024-02-03 10:39:14

Tags for this article:

Click the tags to see associated articles and topics

Neuro Biotech Alto Adds $128M in IPO Cash for Biomarker-Based Psych Drugs. View article details on hiswai:

Excerpt

Alto Neuroscience, biopharma nl, biotech IPO, Clinical Trials, depression, neuroscience, Precision Medicine. Hear the latest industry news first ...

Article found on: medcitynews.com